Maurice G. Russel
Medisch Spectrum Twente
Quality of lifeEpidemiologyInternal medicineSurgeryPathologyHealth carePhysical therapyProspective cohort studyInfliximabInflammatory bowel diseaseDiseaseCrohn's diseaseAdalimumabUlcerative colitisPopulationIncidence (epidemiology)Family medicineMedicineCohortGastroenterology
103Publications
38H-index
3,993Citations
Publications 102
Newest
#1Pepijn W. A. Thomas (Radboud University Nijmegen)H-Index: 1
#2Tessa E H Römkens (Bosch)H-Index: 13
Last. Frank Hoentjen (Radboud University Nijmegen)H-Index: 16
view all 8 authors...
BACKGROUND Only limited data is available on the extent and burden of adverse drug reactions (ADRs) to biological therapy in inflammatory bowel disease (IBD) patients in daily practice, especially from a patient's perspective. OBJECTIVE The aim of this study was to systematically assess patient-reported ADRs during biological therapy in IBD patients and compare these with healthcare provider (HCP)-reported ADRs. METHODS This multicentre, prospective, event monitoring study enrolled IBD patients ...
Source
Source
Source
Source
#1Lauranne A A P Derikx (Radboud University Nijmegen)H-Index: 11
#2Marten A. Lantinga (Radboud University Nijmegen)H-Index: 9
Last. Frank Hoentjen (Radboud University Nijmegen)H-Index: 16
view all 25 authors...
BACKGROUND AND AIMS The COVID-19 risk and disease course in inflammatory bowel disease [IBD] patients remains uncertain. Therefore, we aimed to assess the clinical presentation, disease course, and outcomes of COVID-19 in IBD patients. Second, we determined COVID-19 incidences in IBD patients and compared this with the general population. METHODS We conducted a multicentre, nationwide IBD cohort study in The Netherlands and identified patients with COVID-19. First, we assessed the COVID-19 disea...
12 CitationsSource
#1Pepijn W. A. Thomas (Radboud University Nijmegen)H-Index: 1
#2Rachel L. WestH-Index: 16
view all 9 authors...
Purpose To assess the agreement between patient-reported and health care provider-reported medical information in inflammatory bowel disease (IBD). Methods This multicentre, prospective, event monitoring study enrolled adult Crohn's disease (CD) and ulcerative colitis (UC) patients treated with a biological in four medical centres in the Netherlands. At two-monthly intervals, patients completed questionnaires on biological use, combination therapy and indication. The patient-reported information...
1 CitationsSource
#1Eline L. GiraudH-Index: 1
#2Ibdream registry (Radboud University Nijmegen)
Last. Frank Hoentjen (Radboud University Nijmegen)H-Index: 16
view all 11 authors...
INTRODUCTION Inflammatory bowel disease (IBD) frequently requires chronic immunosuppressive treatment and active involvement from patients during treatment decision making. Information about the risk of developing adverse drug reactions (ADRs) to IBD therapies is required in this process. OBJECTIVE The aim of this study was to describe the ADRs reported in IBD patients from real-world data, using the Dutch nationwide IBDREAM registry, and compare the occurrence and cumulative incidences with the...
Source
#1Michiel E. de Jong (Radboud University Nijmegen)H-Index: 3
#2Erik Taal (UT: University of Twente)H-Index: 51
Last. Maurice G. RusselH-Index: 38
view all 9 authors...
There is a need for easy-to-use patient-reported outcome measures (PROMS) in inflammatory bowel disease (IBD) practice. The ‘IBD-control’ is a short IBD-specific questionnaire capturing disease con...
2 CitationsSource
#1M E de Jong (Radboud University Nijmegen)H-Index: 1
#2Lisa J T Smits (Radboud University Nijmegen)H-Index: 6
Last. Frank Hoentjen (Radboud University Nijmegen)H-Index: 16
view all 9 authors...
BACKGROUND AND AIMS: There is paucity of data on safety and efficacy of anti-TNF in elderly inflammatory bowel disease (IBD) patients. We aimed to compare the long-term treatment failure rates and safety of a first anti-TNF agent in IBD patients between different age groups ( /=60 years). METHODS: IBD patients who started a first anti-TNF agent were identified through IBDREAM, a multicentre prospective IBD registry. Competing risk regression was used to study treatment failure, defined as time t...
11 CitationsSource
#1Pepijn W. A. Thomas (Radboud University Nijmegen)H-Index: 1
#2Rachel WestH-Index: 6
Last. Frank Hoentjen (Radboud University Nijmegen)H-Index: 16
view all 8 authors...
1 CitationsSource